Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the adoption of new technologies for the diagnosis of pancreatic cancer.

As set out in our 10-Year Health Plan, the Government is supporting NHS England to actively adopt new technologies for cancer diagnosis, with focus on artificial intelligence (AI), liquid biopsies, and advanced genomic testing to speed up diagnosis and improve patient outcomes. As part of the plan, we have also committed to the expansion of the National Institution of Clinical Excellence’s technology appraisal process to cover devices, diagnostics, and digital products.

We have invested £146 million in a partnership with pharmaceutical companies and universities to harness science and innovation to detect and treat cancer sooner through trials for new technologies, including those using AI, two of which are developing technology for the diagnosis of pancreatic cancer.

Additionally, initiatives using digital technology to improve the identification of cancer symptoms in primary care include a new £2 million National Health Service programme, funding 300 general practices (GPs) to identify pancreatic cancer early by screening high-risk patients over 60 years old with new diabetes diagnoses and unexplained weight loss for urgent testing. More than 300 GPs across England will begin using the initiative, with the roll out having already begun, and the rest to be up and running by the end of the year.